The 2018 ranking is an improvement on last year’s rank of 63
Significant investment at Kulmbach site expands capacity of specialist therapeutic oligonucleotide development solutions business
Investment follows other acquisitions in oligonucleotide reagent and synthesised oligonucleotides markets
National Measurement Laboratory at LGC welcomes recent special report
Replaces Dr Derek Craston, who completed two terms of five years each in this Office
Lucigen offers extensive enzymology expertise and a wide portfolio of molecular biology reagents
LGC operates out of 22 countries, with laboratories and centres across Europe and the US, as well as sites in Brazil, China and India.